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Office-based simple frailty score 
and central blood pressure predict 
mild cognitive impairment in an 
apparently healthy Japanese 
population: J-SHIPP study
Maya Ohara1, Katsuhiko Kohara2, Yoko Okada1, Masayuki Ochi1, Tokihisa Nagai1, 
Yasumasa Ohyagi1, Yasuharu Tabara3 & Michiya Igase1
Frailty is associated with cognitive impairment and can be used to identify people at high risk for 
dementia. We developed a simple frailty (SF) score using a combination of low hand grip strength 
(<32.5 kg in men, <19.5 kg in women), and short one-leg standing time (<20 seconds). These can be 
easily measured in the clinician’s office when seeing patients. We investigated the possible association 
between SF score and mild cognitive impairment (MCI) in a cross-sectional study with 838 independent 
middle-aged to elderly participants (319 men, mean age 65.1years). In total, 118 participants were 
diagnosed with MCI. A SF score of 2 was significantly associated with the presence of MCI (odds ratio 
4.6, 95% confidence interval: 1.9–6.9, p = 0.0001) even after adjustment for age and sex. Stepwise 
regression analyses showed that a SF score of 2 was associated with the presence of MCI, independently 
of central pulse pressure and silent cerebral infarcts. These findings indicate that the SF score is a useful 
frailty parameter to predict MCI in an apparently independent population.
Identification of people at high risk for dementia is a corner-stone, early intervention strategy to prevent pro-
gression to dementia. Mild cognitive impairment (MCI), especially amnestic MCI, is a prodrome of dementia 
(including Alzheimer’s disease) and has been researched as a possible target for early intervention1. Recent con-
sensus from the International Association of Gerontology and Geriatrics stresses the importance of case-findings 
by physicians and health professionals2.
Frailty is a state of increased vulnerability owing to poor resolution of homoeostasis after a stressor event that 
increases the risk of adverse outcomes, including disability3. A close association between frailty and dementia 
has been demonstrated4. Criteria proposed by Fried et al.5 are most frequently used in clinical practice, and com-
prise three or more of five conditions: slowness, weakness, shrinking, inactivity and exhaustion. Slow walking 
speed, a component of frailty, has also been significantly associated with MCI6 and future development of MCI7. 
Subjective cognitive decline in combination with slow gait speed has been defined as motoric cognitive risk syn-
drome8, which was reported to be a risk factor for future development of dementia9.
Recently, we developed a simple frailty (SF) score using the combination of low hand grip strength and short 
one-leg standing (OLS) time, both of which can be easily measured in the clinician’s office10. SF score was sig-
nificantly associated with systemic frailty, including cognitive function10. In addition, SF score was significantly 
associated with advanced end organ damage including brain small vessel disease (SVD)10.
Based on these findings, we hypothesised that SF score could predict the presence of MCI in an apparently 
healthy and independent population, and may be a useful tool to identify people at high risk. We investigated the 
possible association between SF score and MCI in a cross-sectional study. We also evaluated SF strict score based 
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on the Asian definition of sarcopenia11. Further, we evaluated pulmonary function, arterial stiffness, central blood 
pressure (BP) and SVD as possible mechanisms underlying the association between SF score and MCI.
Methods
Study participants. The study population comprised 864 consecutive middle-aged to elderly participants 
who attended the medical check-up programme at the Ehime University Hospital between March 2006 and 
December 2014. Of the 864 participants who completed MCI screening, we analysed data for 838 who agreed 
with the study aims and protocols and had no history of symptomatic cardiovascular events (including stroke, 
transient ischaemic attack, coronary heart disease or congestive heart failure). Written informed consent for all 
procedures was obtained from all participants. This cross-sectional investigation was conducted as part of the 
Shimanami Health Promoting Program (J-SHIPP study), a longitudinal study evaluating factors related to car-
diovascular disease, dementia and death10. The J-SHIPP series of studies was approved by the Ethics Committee 
of the Ehime University Graduate School of Medicine. All studies were performed in accordance with relevant 
guidelines and regulations.
SF score. Participants were scored 1 point if their OLS time was < 20 s, and 1 point if their hand grip strength 
was < 32.5 kg (men) or < 19.5 kg (women); these scores were summed to give the SF score10. We also analysed 
SF score using the Asian definition of sarcopenia (grip strength < 26 kg in men or < 18 kg in women), defined as 
participants’ SF strict score11.
Further we also evaluated the prediction of MCI using a definition of low grip strength (men < 39 kg and 
women < 20.3 kg) and low OLS time (< 35.2 s) from the ROC curve for each parameter.
Hand grip strength. Hand grip strength was measured using a digital hand dynamometer (T.K.K. 5410; Takei 
Scientific Instruments Co. Ltd., Niigata, Japan), performed once on each side; the highest value was used for 
analysis12. The dynamometer’s minimum detectable hand grip strength was 0.1 kg. All participants who per-
formed hand grip strength measurements were free from any condition (such as arthralgia) that might inter-
fere with measurement. The cut-off value for the SF score in our study population was based on the bottom 
20% in each sex. The intra-measurement reproducibility coefficient of variation (CV) was 5.0 ± 3.2% and the 
inter-measurement CV was 5.2 ± 3.7%12.
OLS test. The OLS test was performed with eyes open and measured using the leg selected by the participant. 
The time interval until the raised leg was put down was measured twice, with a maximum time of 60 s allowed. 
The better of the two recordings was used for statistical analysis. The cut off value for OLS time (less than 20 s) was 
based on previous findings13.
Assessment of MCI. MCI was assessed using the Japanese version of the MCI screening method (MCI 
Screen), a 10-minute, computationally scored, staff-administered test14. The methodology for scoring the MCI 
Screen was developed by the Medical Care Corporation (Irvine, CA, USA). The MCI Screen is a brief neuropsy-
chological test derived from the protocol of the Consortium to Establish a Registry for Alzheimer’s Disease 
10-word recall test. The MCI Screen comprises three immediate recall tasks, a triadic comparison task, a judg-
ment task, a delayed free recall task, a cued-recall task and a rehearsed recall task. MCI Screen results were sub-
mitted to the online analysis centre, and points scored by each screening test participant were used to diagnose 
MCI. Validity and specificity in the differentiation of normal aging from MCI and mild dementia have been 
described elsewhere, and the overall accuracy in discriminating both amnestic and mixed cognitive domain types 
of MCI from normal aging is 97%14. The MCI Screen has been translated into Japanese, and cross-validation has 
been confirmed using the Clinical Dementia Rating Scale as a reference (overall accuracy: 96.4%)15.
Pulse wave velocity (PWV). PWV was measured using a volume-plethysmograph (PWV/ABI; Omron 
Healthcare Co. Ltd., Japan). A detailed description of this device and the validity and reproducibility of its meas-
urements have been published elsewhere16. Brachial-to-ankle PWV (baPWV) was calculated using the time inter-
val between the wave fronts of the brachial and ankle waveforms (∆ Tba) and the path length from the brachium 
to the ankle. Path lengths from the suprasternal notch to the brachium (Lb) or ankle (La) were calculated using 
the formulae: Lb = 0.2195 × height + 2.0734; La = 0.8129 × height + 12.328. Then, baPWV was calculated using 
the equation (La− Lb)/∆ Tba.
Radial waveform analysis and blood pressure (BP) measurement. The left radial artery pulse wave-
form was measured using an automated tonometric method (HEM-9000AI; Omron Healthcare Co. Ltd.) with 
participants in a sitting position after at least 5 min of rest. Brachial BP was measured simultaneously in the 
right brachium with an oscillometric device incorporated in the HEM-9000AI. The HEM-9000AI device is pro-
grammed to automatically adjust the pressure against the radial artery to obtain the optimal arterial waveform. 
Late systolic second peak BP (SBP2) was calculated by calibration with brachial systolic BP (SBP). Pulse pres-
sure (PP) was calculated as PP = SBP − diastolic BP (DBP), and PP2 was calculated as SBP2 − DBP. The radial 
augmentation index (AI) was calculated as PP2/PP × 100(%)17. All measurements were repeated twice and the 
mean values were used for subsequent analyses. Radial AI and PP2 have been shown to accurately reflect transfer 
function-derived aortic AI and aortic PP, and were used as central BP-related values17.
Assessment of silent brain lesions by magnetic resonance imaging (MRI). In 733 participants, 
silent cerebral infarcts and white matter hyperintensities (WMHs), including periventricular hyperintensity 
(PVH) and deep subcortical white matter hyperintensity (DSWMH), were evaluated based on brain MRI find-
ings using a 3-tesla scanner (Signa Excite 3.0 T; GE Healthcare, Milwaukee, WI, USA). Detailed methods have 
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been previously reported13. In brief, silent lacunar infarction (SLI) was defined as areas of low signal intensity 
(3–15 mm diameter) on T1-weighted images, and areas of high intensity on T2-weighted and fluid-attenuated 
inversion recovery (FLAIR) images. Hyperintensities depicted on T2-weighted and FLAIR images in contact with 
the ventricular wall and located in the subcortical region were defined as PVH and DSWMH, respectively. PVH 
was further classified in five grades based on Japanese guidelines13: grade 0 = absent or only a ‘rim’; grade 1 = lim-
ited lesion-like ‘caps’; grade 2 = irregular ‘halo’; grade 3 = irregular margins and extension into the deep white 
matter; and grade 4 = extension into the deep white matter and subcortical portion. DSWMH was also classified 
in five grades13: grade 0 = absent; grade 1 = ≤ 3 mm small foci and regular margins; grade 2 = ≥ 3 mm large foci; 
grade 3 = diffusely confluent; and grade 4 = extensive changes in the white matter. The presence of WMHs was 
defined as PVH grade ≥ 2 and/or DSWMH grade ≥ 3. Images were analysed by two neurologists without clinical 
information about the participants. Images were analysed using OsiriX software (http://www.osirixviewer.com/).
Postural instability. Postural instability was measured with a posturograph (Gravicorder G-5500; Anima 
Inc., Tokyo, Japan). This consists of an equilateral triangular footplate with three built-in vertical force transducers 
that determine instantaneous fluctuations in the centre of pressure10. Signals were processed by a direct-coupled 
amplifier and low-pass filters (cut-off frequency 10 Hz) and stored in a computer after analogue–digital conver-
sion at a sampling rate of 20 Hz. Participants were instructed to maintain a static upright posture on the foot-
plate with their feet together and watch a circular achromatic target placed 2 m in front of their eyes. Data were 
acquired for 1 min, beginning after the participant’s posture had stabilised. All measurements were performed 
barefoot with both arms held at the side of the body. Path lengths of the centre of pressure movement were consid-
ered parameters for movement of centre of gravity, and used as indices of postural stability10. Postural instability 
was defined as a path-length of centre of gravity of 86.92 cm or more by a ROC curve for the presence of MCI.
Pulmonary function. Pulmonary function was measured using a spirometer (Microspiro HI-801; CHEST 
M.I., Inc., Tokyo, Japan) in 826 participants. Vital capacity (VC), forced vital capacity (FVC), and forced expira-
tory volume in 1 s (FEV1.0) were measured, and %VC and FEV1.0% were calculated10.
Risk factor evaluation. Participants’ lifestyles, medical histories, and use of prescribed drugs were assessed 
with a questionnaire. All anthropometric measurements were performed by a trained nurse. Hypertension was 
defined as (any or all) SBP ≥ 140 mmHg, DBP ≥ 90 mmHg or use of an antihypertensive drug. Type 2 diabetes was 
defined as (any or all) fasting plasma glucose ≥ 7.0 mmol/L, HbA1c ≥ 6.5% or use of medication to lower blood 
glucose levels. Dyslipidemia was defined as (any of all) low-density lipoprotein cholesterol ≥ 3.63 mmol/L, tri-
glyceride ≥ 1.70 mmol/L, high-density lipoprotein cholesterol < 1.04 mmol/L or use of medication to treat serum 
lipid abnormalities. A clinical diagnosis of sleep apnoea syndrome (SAS) was also collected by the questionnaire.
Other possible confounding parameters. We evaluated oxygen saturation (SpO2) during sleep and 
physical activity in limited numbers of participants as possible confounding parameters.
SpO2 during sleep. In 587 participants, SpO2 during sleep was continuously measured for one night using 
a pulse oximeter (PULSOX-Me300, Nihon Kohden, Co., Tokyo, Japan), with a finger-type probe that measured 
light absorption at 665 and 880 nm (LM-5C, Nihon Kohden). Mean SpO2 during sleep and 3% oxygen desatura-
tion index (3% ODI), namely the number of SpO2 drops greater than 3% per hour, were calculated with dedicated 
Windows software (DS-Me, Nihon Kohden), using data stored in the equipment, and bed and wake-up times 
obtained by the questionnaire18.
Physical activity. In 566 participants, whole day physical activity was measured with an accelerometer 
(Lifecorder EX device, Suzuken, Co., Nagoya, Japan) for consecutive 2 to 7 day periods. Data were retrieved with 
manufacturer-provided physical activity analysis software, and mean daily motor activity, expressed as calorie 
expenditure by physical activity, and number of steps were used as indices for physical activity19.
Statistical analyses. Differences in numeric variables were assessed using analysis of variance. Frequency 
differences were assessed with χ 2 tests. Covariate adjustment was performed by linear regression analysis. 
Covariate-adjusted odds ratios for the presence of MCI were evaluated with logistic regression analysis. All statis-
tical analyses were performed with commercially available statistical software (JMP version 10.0.2; SAS Institute 
Inc., Cary, NC, USA), and p < 0.05 was considered statistically significant.
Results
Clinical characteristics of MCI. The clinical characteristics of the study population by the presence/absence 
of MCI are summarised in Table 1. MCI was observed in 14.1% of participants, and was more prominent in 
men. Participants with MCI were significantly older than those without MCI. PP, especially radial PP2, was sig-
nificantly higher in participants with MCI, whereas other parameters showed no significant differences after 
adjustment for age and sex. Participants with MCI had significantly higher SF scores and SF strict scores (Fig. 1, 
Supplementary Fig. 1). Odds ratios for an SF score of 2 to a score of 0 for MCI were significantly higher, even after 
adjusting for possible confounding parameters. For SF strict scores, a score of 1 was significantly associated with 
MCI. Associations with each component of SF score and SF strict score are shown in Supplementary Figs 2 and 3, 
indicating that short OLS time accounted for the presence of MCI.
With ROC curve obtained definition, sex and age adjusted odds ratios for the presence of MCI were: SF score 
1 to 0, 1.54 (0.88–2.75, p = 0.13) and SF score 2 to 0, 3.39 (1.81–6.42, p = 0.0001).
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MCI and central BP. Brachial PP and radial PP2 were significantly higher in participants with MCI. 
Interactions between SF score and MCI status on PP and PP2 were further evaluated (Fig. 2). Both SF score and 
MCI were significantly associated with PP and radial PP2. However, baPWV (another stiffness index) was only 
associated with SF score. Similar findings were observed for SF strict score (Supplementary Fig. 4).
MCI (−) MCI (+) P
N 720 118
Male, n (%) 255 (35) 64 (54) < 0.0001
Age, years 64.0 (9.6) 71.9 (7.9) < 0.0001
Body height, cm 159.3 (5.4) 158.1 (5.4) 0.03
Body weight, kg 59.9 (8.6) 59.3 (8.6) 0.55
Body mass index, kg/m2 23.5 (3.2) 23.6 (3.2) 0.72
Systolic blood pressure, mmHg 132.0 (18.6) 134.4 (18.5) 0.19
Diastolic blood pressure, mmHg 75.8 (11.3) 74.7 (11.1) 0.37
Pulse pressure, mmHg 56.2 (13.4) 59.7 (13.3) 0.01
Radial Systolic blood pressure 2, mmHg 124.4 (19.3) 127.4 (19.2) 0.13
Radial pulse pressure2, mmHg 48.7 (14.0) 52.6 (13.9) 0.005
Heart rate, beats/min 65.7 (9.7) 66.3 (9.7) 0.52
Triglyceride, mg/dl 110.6 (61.2) 111.5 (60.6) 0.89
Total cholesterol, mg/dl 215.7 (38.1) 213.6 (37.7) 0.58
HDL cholesterol, mg/dl 64.5 (16.9) 64.7 (16.6) 0.92
Fasting glucose, mg/dl 103.8 (19.6) 105.6 (19.3) 0.34
Insulin, pg/ml 6.3 (4.6) 5.7 (4.5) 0.18
Antihypertensive drugs use, n (%) 217 (30) 46 (39) 0.39
Antidyslipidemia drugs use, n (%) 194 (27) 34 (29) 0.48
Antidiabetic drugs use, n (%) 37 (5) 14 (12) 0.09
Hypertension, n (%) 342 (48) 76 (64) 0.65
Dyslipidemia, n (%) 485 (67) 77 (65) 0.67
Diabetes, n (%) 54 (9) 21 (19) 0.21
Sleep apnoea, n (%) 36 (5) 4 (4) 0.43
Smoking status 45/187/488 9/37/72 0.33
Physical activity status 106/384/185/45 35/60/20/3 0.52
baPWV, cm/sec (n = 835) 1564 (295) 1592 (292) 0.34
MRI findings (n = 733) N = 632 N = 101
Silent lacunar infarct, n (%) 74 (12) 27 (27) 0.02
PVH > = 2, n (%) 99 (16) 33 (33) 0.30
DSWMH > = 3, n (%) 48 (8) 20 (20) 0.10
WMH, n (%) 113 (18) 36 (36) 0.29
Saturation monitor during sleep (n = 587) N = 511 N = 76
Mean SpO2 95.9 (1.3) 96.1 (1.3) 0.37
3% ODI, events/hr 8.8 (7.8) 8.8 (7.1) 0.56
Dip bottom SpO2 91.4 (2.1) 91.5 (2.1) 0.60
Respiratory function (n = 826) N = 709 N = 117
Vital capacity, L 2.76 (0.5) 2.64 (0.5) 0.02
%VC, % 101.0 (17.5) 96.4 (18.2) 0.01
Forced VC, L 2.50 (0.5) 2.42 (0.5) 0.16
FEV1.0, L 2.15 (0.4) 2.08 (0.5) 0.13
FEV1.0%, % 90.9 (8.4) 90.8 (8.3) 0.94
Active meter (n = 566) N = 495 N = 71
Mean motor activity, kcal/day 175.8 (86.2) 180.8 (10.527) 0.66
Steps, number/day 7169 (2857) 7131 (2938) 0.92
Table 1.  Clinical characteristics of the study population by the presence/absence of mild cognitive 
impairment. Values are mean (standard deviation) or number (%). MCI, mild cognitive impairment; HDL, 
high density lipoprotein; baPWV, brachial-ankle pulse wave velocity; MRI, magnetic resonance imaging; PVH, 
periventricular hyperintensity; DSWMH, deep subcortical white matter hyperintensity; WMH, white matter 
hyperintensity; SpO2, oxygen saturation; ODI, oxygen desaturation index; VC, vital capacity; FEV 1.0, forced 
expiratory volume in one second. All values except for age, sex and MRI parameters were adjusted for age and sex.
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MCI, SF score and SVD. In a separate analysis, the presence of SLI was significantly associated with MCI 
after adjusting for sex and age, whereas WMH was not (Table 1). We further evaluated the possible interaction 
between SVD parameters and SF score for the presence of MCI (Fig. 3). Even after adjusting for age and sex, SF 
score and SLI were independently associated with the presence of MCI. However, inclusion of SF strict score 
eliminated the statistical significance of WMH (Supplementary Fig. 5).
To determine possible independent predictors for the presence of MCI, we performed stepwise logistic 
regression analyses in several models (Table 2). In the total population, a SF score of 2 and high PP2 were inde-
pendently associated with MCI in addition to age and male sex. Similar findings were obtained for SF strict score 
(Supplementary Table 1). Further, analyses including MRI parameters, baPWV and pulmonary functions showed 
that a SF score of 2, SF strict scores of 1 and 2, radial PP2 and SLI were independent predictors for the presence of 
MCI (Table 3, Supplementary Table 2).
Postural instability and MCI. As short OLS time was associated with MCI, the relationship between 
postural instability and MCI was further investigated using the path-length of centre of gravity as an index 
for postural instability. The path-length of centre of gravity was significantly higher in participants with MCI 
and those with WMH (Supplementary Fig. 6). Further, the interaction between postural instability and SVD 
was investigated. Postural instability was significantly associated with the presence of MCI, in addition to SLI 
(Supplementary Fig. 7).
Discussion
We demonstrated that an office-based easily obtainable SF score predicted the presence of MCI in an apparently 
healthy, independent population. We also demonstrated that central PP elevation and SLI were independently 
associated with MCI. These findings indicate that physical frailty underlies MCI, in addition to subclinical brain 
damage and central hemodynamic alteration.
The close association between cognitive impairment and frailty has been previously studied20,21. We recently 
reported that an easily measured simple physical frailty score can show systemic frailty (including cognitive func-
tion) as well as advanced end organ damage10. In the present study, we showed that the SF score (combination of 
hand grip strength and OLS time) is useful to predict the presence of amnestic MCI. Further analysis revealed that 
low hand grip strength alone was not associated with MCI, although it was significantly associated with cognitive 
test score in both men and women (data not shown). SF strict score based on the Asian definition of sarcopenia (grip 
strength of 26/19 kg) significantly predicted the presence of MCI. Interestingly, postural instability also significantly 
predicted the presence of MCI. However, the association between OLS time and path-length of centre of gravity was 
modest (r = − 0.39, p < .0001); indicating short OLS time was not only a reflection of postural instability.
Figure 1. Simple frailty score and the presence of mild cognitive impairment. The closed column indicates 
the number of participants with mild cognitive impairment (MCI), and the open column indicates those 
without MCI. The number in the column represents the number of participants. The odds ratio on the right 
side indicates the odds ratio of a simple frailty (SF) score of 1 and a SF score of 2 to an SF score of 0 for the 
presence of MCI. Adjustment 1: adjusted for age and sex. Adjustment 2: adjusted for age, sex, body mass index, 
mean blood pressure, triglyceride, total cholesterol, high-density lipoprotein cholesterol, glucose, insulin, use 
of antihypertensive drugs, antidyslipidemic drugs, diabetic drugs, current smoking, physical activity and the 
presence of silent cerebral infarctions and white matter hyperintensity. Adjustment was performed by logistic 
regression analyses for the presence of MCI. OR, odds ratio; CI, confidence interval.
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Several studies have reported an association between low hand grip strength and slow processing speed22 
and dementia23,24. In our study, short OLS time alone was significantly associated with MCI. However, short 
OLS time combined with low hand grip strength further increased the odds ratio for the presence of MCI 
(Supplementary Figs 2 and 3), indicating a synergistic effect between hand grip strength and OLS time as an 
index for frailty.
Although our original SF score predicted the presence of end-organ damage10, we also evaluated this asso-
ciation using a more strict definition of low grip strength (Asian definition of sarcopenia). Interestingly, this SF 
strict score was significantly and independently associated with MCI (even a SF strict score of 1) indicating that 
the Asian definition may be most suitable for such a prediction. We also evaluated the prediction of MCI using a 
definition of low grip strength and low OLS time from the ROC curve for each parameter. With this definition, 
Figure 2. Relationship between simple frailty (SF) score, mild cognitive impairment (MCI) and brachial 
pulse pressure 2 (PP2), brachial pulse pressure (PP) and brachial-ankle pulse wave velocity (baPWV). The 
number in the column represents the number of participants. Adjustment was made for age, sex and mean 
blood pressure. Adjustment was performed using linear regression analysis with interactions between SF score 
and MCI presence.
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sex and age adjusted odds ratios for the presence of MCI were similar to our original SF score. These findings also 
increased the complexity of determining cut-off values for the SF score.
Cardiovascular risk factors have been shown to be involved in the development of MCI25,26. However, we 
found that only BP parameters were related to amnestic MCI after adjustment for age and sex. As there was a 
significant difference in age and sex between participants with and without MCI, adjustment for age might have 
obscured possible associations. In our raw data, the prevalence of hypertension and diabetes was significantly 
higher in participants with MCI. MCI was also associated with higher PP, especially radial PP2 (a surrogate index 
for aortic PP). We demonstrated that low hand grip strength was associated with high central BP via arterial 
stiffness12. Therefore, we speculated that SF score may underlie the association between high central PP and MCI. 
However, stepwise logistic regression analysis showed that radial PP2 and SF score were independently associated 
with the presence of MCI.
The advantage of the SF score is that it is easily measured in the clinician’s office during patient visits, whereas 
gait speed measurement requires a straight line distance of 5–6 meters to walk. SF score may therefore be a useful 
tool to support case-findings by physicians and health professionals in their daily practice. In addition, SF score 
Figure 3. Relationship between simple frailty (SF) score, presence of silent lacunar infarction (SLI), white 
matter hyperintensity (WMH) and mild cognitive impairment (MCI). The number in the column represents 
the number of participants. The number above the column indicates the prevalence (%) of MCI. Adjustment for 
age and sex was performed with logistic regression analyses with interactions between SF score and the presence 
of SLI or WMH.
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does not depend on assessment of cognitive function, which may make patients uncomfortable, especially those 
without subjective symptoms.
Identification of MCI is clinically useful for early intervention in the development of dementia, as well as for 
careful management of BP. To date, there has been no data available about how BP should be controlled in patients 
N = 838 Odds ratio 95% CI P
Sex, male = 1 2.66 1.73–4.14 0.0004
Age, 10 years 2.03 1.49–2.80 < 0.0001
Body mass index
Mean blood pressure, mmHg
Brachial pulse pressure, 10 mmHg









Current smoking, yes = 1
Physical activity1)
Simple frail score 1 vs. 0 1.52 0.92–2.51 0.10
Simple frail score 2 vs. 0 3.58 1.86–6.86 0.0001
Table 2.  Stepwise logistic regression analysis for the presence of mild cognitive impairment in the total 
study population. HDL, high-density lipoprotein; IRI, immune-reactive insulin; CI, confidence interval. 1) 
Physical activity (every day = 1, sometimes = 2, not often = 3, never = 4). Blank columns indicate parameters 
not entered in the equation.
N = 733 Odds ratio 95% CI P
Sex, male = 1 2.34 1.48–3.74 0.003
Age, 10 years 1.88 1.35–2.65 0.0001
Body mass index
Mean blood pressure, mmHg
Brachial pulse pressure, 10 mmHg









Current smoking, yes = 1
Physical activity1)
baPWV, 100 cm/sec
Silent lacunar infarct, yes = 1 1.83 1.04–3.14 0.035
White matter hyperintensity, yes = 1
%VC, %
FEV1.0%, %
Simple frail score 1 vs. 0 1.37 0.80–2.34 0.25
Simple frail score 2 vs. 0 2.99 1.46–6.04 0.003
Table 3.  Stepwise logistic regression analysis for the presence of mild cognitive impairment, including 
brain lesions. HDL, high-density lipoprotein; IRI, immune-reactive insulin; CI, confidence interval; VC, vital 
capacity; FEV1.0%, forced expiratory volume % in one second. Physical activity (every day = 1, sometimes = 2, 
not often = , never = 4). Blank columns indicate parameters not entered in the equation.
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with hypertension who also have cognitive impairment or dementia27. A recent sub-analysis of older adults in 
the Systolic Blood Pressure Intervention Trial (SPRINT) study indicated that irrespective of levels of frailty, strict 
management of SBP (as low as 120 mmHg) in older adults aged over 75 years significantly reduced cardiovas-
cular events and total mortality28. In contrast, Mossello et al.29 reported that lowering SBP (< 125 mmHg) using 
antihypertensive drugs increased the progression of cognitive decline in patients with hypertension and MCI or 
dementia. Several other studies have also reported a possible negative effect of extensive BP reduction on cog-
nitive function30,31. These findings indicate it is important to detect cognitive impairment in older adult patients 
with hypertension to determine appropriate levels for BP control.
Associations between respiratory disorders, including SAS and chronic obstructive pulmonary disease, and 
MCI have been demonstrated32,33. In the present study, the prevalence of SAS and nocturnal decline of SpO2 did 
not significantly differ after correction for age and sex (Table 1). Pulmonary function, especially VC and %VC, 
showed a significant declined in participants with MCI. However, in the logistic regression analyses, pulmonary 
functions were not independently associated with MCI. As a close association between sarcopenia and pulmo-
nary dysfunction has been demonstrated10, SF score could include pulmonary dysfunction.
There are several limitations to consider in interpreting our results. The cross-sectional nature of the study 
design does not show causality between higher SF scores and MCI. Since we quantified physical activity by 
accelerometer in only limited number of subjects, we used physical activity score in stepwise logistic analyses. 
Although physical activity scores were significantly related to both mean daily energy expenditure by physical 
activity and steps measured by accelerometer (data not shown), physical activity score was too simple to quantify 
the physical activity. Given the relatively healthy study population, our findings may not be applicable for more 
frail patients, including those residing in nursing homes. Replication with a large sample of heterogeneous sub-
jects in a longitudinal observation would be necessary to confirm our findings. Sub-analysis of cognitive function 
in SPRINT study may provide further insight for the management of BP in patients who are hypertensive and 
have cognitive impairment.
In summary, SF score is a significant predictor of the presence of MCI, independent of central PP and sub-
clinical brain damage, which are also associated with SF score. Our findings further support a close association 
between physical frailty and cognitive impairment. Our simple, office-based evaluation of frailty may help to 
identify older adults at high risk for frailty and MCI to guide further intervention.
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